Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 8/13/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Mark J. Rivard PhD

Wrong Dr. Mark J. Rivard PhD?

Professor of Radiation Oncology

Phone: (617) ***-****  
Email: m***@***.org
Tufts Medical Center
800 Washington Street #231
Boston , Massachusetts 02111
United States

Company Description: Tufts Medical Center is an exceptional, not-for-profit, 415-bed academic medical center that is home to both a full-service hospital for adults and Floating...   more

Employment History


  • PhD
30 Total References
Web References
Advanced brachytherapy for physicists, 21 May 2014 [cached]
Mark Rivard, Physicist, Tufts University School of Medicine, Boston (US)
AAPM Individual Appointments, 25 June 2012 [cached]
Mark Rivard - Brachytherapy Physics Representative - [Report to Committee: TPC]
Acuros BV advanced dose calculation for brachytherapy, 29 Dec 2013 [cached]
Mark Rivard, Tufts Medical Center Physicist, offers his thoughts on how to implement Acuros BV.
Learn more about the TG 186 Task Group report from Mark Rivard, PhD of Tufts Medical Center. The TG 186 Task Group focused on model-based algorithms in brachytherapy. Dr. Rivard was a member of the task group and continues to be involved in the Working Group.
IsoRay, 13 Dec 2007 [cached]
Three patients received implants for intraocular melanoma, which were performed with the support of Mark J. Rivard, Ph.D, Associate Professor of Radiation Oncology at Tufts University School of Medicine and Chief Medical Physicist at Tufts - New England Medical Center.
"Cesium-131's unique characteristics, including minimizing healthy tissue dose, which is a benefit for the patient, may offer significant clinical advantages," said Rivard, who is also a consultant to IsoRay.
Rivard commented, "Cesium-131's higher photon energies provide improved dose homogeneity, and allows the delivery of the required dose while potentially reducing unnecessary dose to surrounding tissue."
Rivard explained that intraocular melanoma tends be most common in individuals over 40 years of age and is most commonly detected in routine eye exams where the pupils are dilated. In other cases, symptoms may include a dark spot on the iris or blurred vision. The course of therapy is dictated by the size of the lesion, and whether the cancer has spread throughout the eye or beyond.
"Brachytherapy has been most effective for small to medium sized tumors," added Rivard.
OUR EXPERT STAFF, 21 July 2006 [cached]
MARK RIVARD, PhDDr. Rivard is an associate professor at the Tufts University School of Medicine, and provides technical and computer support for the Boston Gamma Knife Center.In addition to training at the University of Michigan and Wayne State University, he has worked at Fermilab and Oak Ridge National Laboratory on clinical research projects.In 1999 Dr. Rivard completed residency training and joined the Tufts-NEMC faculty.He is a board-certified medical physicist, and is internationally recognized in the fields of radiation transport calculations and brachytherapy physics.
Other People with the name "Rivard":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.